Trial Profile
The relationship of the effective dose and safety of cinacalcet hydrochloride and etelcalcetide hydrochloride in the Japanese patients with secondary hyperparathyroidism receiving hemodialysis, when switching cinacalcet hydrochloride to etelcalcetide hydrochloride.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2019
Price :
$35
*
At a glance
- Drugs Etelcalcetide (Primary) ; Cinacalcet
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- 13 Mar 2019 Status changed from active, no longer recruiting to completed.
- 05 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 21 Jun 2017 Status changed from not yet recruiting to recruiting.